Concourse Financial Group Securities, Inc. Uni Qure N.V. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
28 transactions
Others Institutions Holding QURE
# of Institutions
216Shares Held
55.1MCall Options Held
4.37MPut Options Held
1.39M-
Rtw Investments, LP New York, NY5.16MShares$159 Million1.1% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$123 Million4.79% of portfolio
-
Vestal Point Capital, LP New York, NY3.7MShares$114 Million2.72% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.63MShares$112 Million0.92% of portfolio
-
Abrdn PLC2.94MShares$90.7 Million0.28% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $1.44B
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...